The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

EAST EASTPHARMA LTD GDR (EACH REPR 1 COM SHR)(REGS)




We are now using data from FTSE Russell Data Solutions. FTSE Russell is a leading global provider of benchmarks, analytics and data solutions with multi-asset capabilities. Global Company Fundamentals provides profiles on global active and inactive companies from over 100 countries including over 25 years of as-reported financials and standardised financials based on globally accepted XBRL taxonomies for active companies. As a result of this change in data provider, you may see some differences to the data. For further information please contact lse-website@lseg.com
Income Statement 31-Dec-12
( $ m )
31-Dec-13
( $ m )
31-Dec-14
( $ m )
31-Dec-15
( $ m )
31-Dec-16
( $ m )
Continuing Operations
Revenue  231.98 217.13 210.53 209.89 224.92
Operating Profit/(Loss)  55.76 42.11 37.60 49.14 56.95
Net Interest  -13.03 -13.32 -17.42 -15.82 -15.97
Profit Before Tax  17.09 1.98 -1.55 14.67 24.26
Profit After Tax  12.34 1.52 -1.14 11.87 18.47
Discontinued Operations
Profit After Tax  n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD  11.60 1.06 -1.55 11.32 18.47
Attributable to:
Minority Interests  -2.52 -1.59 -0.07 -2.62 -3.10
Equity Holders of Parent Company  9.08 -0.53 -1.62 8.70 15.37
 
Continuing EPS
Earnings per Share - Basic  13.00¢ -1.00¢ -2.00¢ 13.00¢ 22.70¢
Earnings per Share - Diluted  13.00¢ -1.00¢ -2.00¢ 13.00¢ 22.70¢
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  13.00¢ -1.00¢ -2.00¢ 13.00¢ 22.70¢
Earnings per Share - Diluted  13.00¢ -1.00¢ -2.00¢ 13.00¢ 22.70¢
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  n/a n/a n/a n/a n/a

Balance Sheet 31-Dec-12
( $ m )
31-Dec-13
( $ m )
31-Dec-14
( $ m )
31-Dec-15
( $ m )
31-Dec-16
( $ m )
Assets
Non-Current Assets
Property, Plant & Equipment  154.64 138.65 130.92 107.64 96.30
Intangible Assets  180.22 174.66 181.46 168.31 161.49
Investment Properties  n/a n/a n/a n/a n/a
Investments  1.42 0.96 0.55 n/a n/a
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  0.00 0.04 0.07 0.07 0.05
  348.18 324.18 323.19 282.68 259.75
Current Assets
Inventories  75.07 77.39 76.18 68.69 57.62
Trade & Other Receivables  36.98 27.21 26.76 26.94 26.13
Cash at Bank & in Hand  18.16 34.01 23.33 15.86 12.46
Current Asset Investments  80.58 58.76 60.08 57.20 39.37
Other Current Assets  0.41 0.48 0.30 0.28 0.10
  212.99 199.37 187.81 170.36 137.57
 
Total Assets  561.17 523.55 511.01 453.05 397.32
 
Liabilities
Current Liabilities
Borrowings  120.60 78.28 85.50 129.79 43.43
Other Current Liabilities  12.15 9.89 9.68 10.53 12.56
  159.82 110.61 116.50 161.35 73.85
 
Net Current Assets  53.17 88.76 71.31 9.01 63.72
 
Non-Current Liabilities
Borrowings  30.23 85.22 85.05 16.71 64.09
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  0.19 0.00 0.00 0.00 0.00
  40.84 94.63 94.39 26.37 73.74
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  247.95 261.25 269.90 256.14 223.36
 
Net Assets  313.23 262.30 241.10 196.90 173.96
 
Capital & Reserves
Share Capital  338.25 338.25 338.25 338.25 338.25
Share Premium Account  99.77 99.77 99.77 99.77 99.77
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  -65.97 -66.50 -68.11 -59.42 -44.04
Shareholders Funds  313.23 262.30 241.10 196.90 173.96
 
Minority Interests/Other Equity  47.29 56.02 59.01 68.43 75.77
Total Equity *   360.52 318.32 300.11 265.33 249.73

Ratios - based on IFRS 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16
Continuing Operations
PE Ratio *   9.23 n/a n/a 8.08 9.69
PEG *   n/a n/a n/a n/a 0.13
Earnings per Share Growth  n/a n/a n/a n/a 74.14%
Dividend Cover *   n/a n/a n/a n/a n/a
Revenue Per Share  341.98¢ 320.95¢ 311.21¢ 310.26¢ 331.56¢
Pre-Tax Profit per Share  25.19¢ 2.92¢ -2.29¢ 21.69¢ 35.77¢
Operating Margin  24.04% 19.39% 17.86% 23.41% 25.32%
Return on Capital Employed  n/a n/a n/a n/a n/a
 
Continuing & Discontinued Operations
Dividend Yield *   n/a n/a n/a n/a n/a
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  196.60¢ 129.55¢ 88.16¢ 42.26¢ 18.43¢
Net Gearing *   42.35% 49.37% 61.06% 66.35% 54.65%

Data provided by FTSE Russell



Market

Company Information
Updated Monthly
Company address Clarendon House, 2 Church Street, Hamilton, HM11, Bermuda
Company website http://www.eastpharmalt...
Market cap(in millions)* £ 49.98
Listing/Admission to trading 18 Jul 2007
Trading service International Order Book
Market Main Market
Listing category Standard GDRs
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
18-Dec-17
FTSE index -
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register US
Segment IOBU
MiFID Status Regulated Market
Exchange market size 20,000
SEDOL B1ZBJ18
ISIN number US27778Q2049



EASTPHARMA S share fundamentals (EAST)